Metraipolis › archive › dc_13a13ee168bf

Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review — Europe PMC PMID:41488631

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41488631
DOI
10.3389/fimmu.2025.1664587
License (as archived)
solo-consultazione
Archived
2026-11-07T12:42:37.431Z
SHA-256 of the archived text
605420de94073a99155e260d6965773f86fbe19fb7a2295b67cb9d9f98f6c29e
Stable URL of this page
https://metraipolis.com/documento/dc_13a13ee168bf

How to cite

Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review — Europe PMC PMID:41488631 — Europe PMC (en), https://europepmc.org/article/MED/41488631 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13a13ee168bf (Metraipolis archive dc_13a13ee168bf, sha256 605420de94073a99155e260d6965773f86fbe19fb7a2295b67cb9d9f98f6c29e)
BibTeX
@misc{dc13a13ee168bf,
  title = {Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review — Europe PMC PMID:41488631},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41488631},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13a13ee168bf; sha256 605420de94073a99155e260d6965773f86fbe19fb7a2295b67cb9d9f98f6c29e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488631. Agents can read the archived copy with the MCP tool read_document.